NeuroMetrix Announces Sleep Indication for SENSUS™ Pain Management System

by admin on July 8, 2013

NeuroMetrix, Inc. , a medical device company focused on the treatment of the neurological complications of diabetes, reported that the SENSUS Pain Management System became the first transcutaneous electrical nerve stimulator to receive 510 clearance from the U.S.

View full post on pain – Yahoo! News Search Results

Previous post:

Next post: